Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Praxiszentrum Alte Mälzerei, Regensburg, Germany.
J Infect Dis. 2022 Jan 18;225(2):190-198. doi: 10.1093/infdis/jiab415.
From a public health perspective, effective containment strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be balanced with individual liberties.
We collected 79 respiratory samples from 59 patients monitored in an outpatient center or in the intensive care unit of the University Hospital Regensburg. We analyzed viral load by quantitative real-time polymerase chain reaction, viral antigen by point-of-care assay, time since onset of symptoms, and the presence of SARS-CoV-2 immunoglobulin G (IgG) antibodies in the context of virus isolation from respiratory specimens.
The odds ratio for virus isolation increased 1.9-fold for each log10 level of SARS-CoV-2 RNA and 7.4-fold with detection of viral antigen, while it decreased 6.3-fold beyond 10 days of symptoms and 20.0-fold with the presence of SARS-CoV-2 antibodies. The latter was confirmed for B.1.1.7 strains. The positive predictive value for virus isolation was 60.0% for viral loads >107 RNA copies/mL and 50.0% for the presence of viral antigen. Symptom onset before 10 days and seroconversion predicted lack of infectivity with negative predictive values of 93.8% and 96.0%.
Our data support quarantining patients with high viral load and detection of viral antigen and lifting restrictive measures with increasing time to symptom onset and seroconversion. Delay of antibody formation may prolong infectivity.
从公共卫生的角度来看,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的有效遏制策略应与个人自由相平衡。
我们从 59 名在门诊中心或雷根斯堡大学医院重症监护室监测的患者中收集了 79 份呼吸道样本。我们通过定量实时聚合酶链反应分析病毒载量,通过即时检测分析病毒抗原,分析症状出现时间以及呼吸道标本中病毒分离物的 SARS-CoV-2 免疫球蛋白 G(IgG)抗体的存在情况。
对于 SARS-CoV-2 RNA 的每个对数 10 水平,病毒分离的优势比增加了 1.9 倍,对于病毒抗原的检测则增加了 7.4 倍,而在症状出现 10 天后则降低了 6.3 倍,而在存在 SARS-CoV-2 抗体的情况下则降低了 20.0 倍。后者得到了 B.1.1.7 株的证实。病毒载量 >107 RNA 拷贝/mL 时病毒分离的阳性预测值为 60.0%,病毒抗原存在时为 50.0%。症状出现前 10 天和血清转换预测无传染性的阴性预测值分别为 93.8%和 96.0%。
我们的数据支持对高病毒载量和检测到病毒抗原的患者进行隔离,并随着症状出现时间和血清转换的增加解除限制措施。抗体形成的延迟可能会延长传染性。